Our laboratory is interested in host-microbiome interactions and carcinogenesis in the genitourinary tract. We use uropathogenic E. coli and Schistosoma haematobium as model pathogens. Through our research, we seek to better understand inflammation and harness its potential for human benefit.
Besides studying the basic biology of genitourinary inflammation and infection, we are also collaborating with Professors Axel Krieger and Michael Keidar to develop novel surgical technologies. Current projects include development of semi-autonomous suturing robots and application of cold atmospheric plasma for bladder cancer and other urologic diagnoses.